This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

JTT-130

Japan Tobacco Inc.

Drug Names(s): JTT-130

Description: JTT-130 inhibits microsomal triglyceride transfer protein, which is involved in the formation of chylomicrons in the intestine and VLDL (very low density lipoprotein) in the liver (VLDL also contributes to the formation of LDL).


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug